enVVeno Medical (NVNO) Amortization of Deferred Charges (2019 - 2026)

enVVeno Medical's Amortization of Deferred Charges history runs 8 years deep, the most recent figure standing at $93000.0 for Q1 2026.

• On a quarterly basis, Amortization of Deferred Charges rose 13.41% year-over-year to $93000.0 in Q1 2026; TTM through Mar 2026 was $364000.0, a 8.66% increase from a year earlier, with the FY2025 full-year figure at $353000.0, up 4.13% from the prior year.
• Amortization of Deferred Charges climbed to $93000.0 in Q1 2026 per NVNO's latest filing, from $86000.0 in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $96000.0 in Q2 2025 and bottomed at $76000.0 in Q4 2022.
• The 5-year median for Amortization of Deferred Charges is $82000.0 (2023), against an average of $83764.7.
• Across the five-year window, Amortization of Deferred Charges dropped 4.65% in 2025 and gained 13.41% in 2026, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $76000.0 in 2022, then climbed by 3.95% to $79000.0 in 2023, then rose by 3.8% to $82000.0 in 2024, then climbed by 4.88% to $86000.0 in 2025, then rose by 8.14% to $93000.0 in 2026.
• Per Business Quant, the three latest NVNO Amortization of Deferred Charges figures stand at $93000.0 (Q1 2026), $86000.0 (Q4 2025), and $89000.0 (Q3 2025).